Response-metrics for acute lung inflammation pattern by cobalt-based nanoparticles

Particle and Fibre Toxicology

Volumn 12, Issue 1, 2015, Pages

  Jeong, Jiyoung ^a   Han, Youngju ^a   Poland, Craig A ^b   Cho, Wan Seob ^a  

^a Dong A University   (South Korea)

^b INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

Author keywords

Co3O4; CoO; Dose metric; High solubility nanoparticles; Intratracheal instillation; Ion metric

Indexed keywords

COBALT; COBALT MONOXIDE NANOPARTICLE; COBALT OXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; COBALT OXIDE; OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE METRIC; EOSINOPHIL; INFLAMMATION; LUNG LAVAGE; LUNG PARENCHYMA; LYSOSOME; MEASUREMENT; NEUTROPHIL; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SOLUBILITY; ACUTE DISEASE; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; FEMALE; IMMUNOLOGY; PARTICLE SIZE; PATHOLOGY; PNEUMONIA; SURFACE PROPERTY;

RATTUS;

ACUTE DISEASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; NANOPARTICLES; OXIDES; PARTICLE SIZE; PNEUMONIA; RATS; SOLUBILITY; SURFACE PROPERTIES;

EID: 84929461894     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/s12989-015-0089-1     Document Type: Article

References (33)

1. Simko M, Nosske D, Kreyling WG. Metrics, dose, and dose concept: the need for a proper dose concept in the risk assessment of nanoparticles. Int J Environ Res Public Health. 2014;11(4):4026-48.
2. Donaldson K, Schinwald A, Murphy F, Cho WS, Duffin R, Tran L, et al. The biologically effective dose in inhalation nanotoxicology. Acc Chem Res. 2013;46(3):723-32.
3. Wittmaack K. In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what? Environ Health Perspect. 2007;115(2):187-94.
4. Kreyling WG, Hirn S, Moller W, Schleh C, Wenk A, Celik G, et al. Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano. 2014;8(1):222-33.
5. Duffin R, Tran L, Brown D, Stone V, Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol. 2007;19(10):849-56.
6. Oberdorster G, Oberdorster E, Oberdorster J. Concepts of nanoparticle dose metric and response metric. Environ Health Perspect. 2007;115(6):A290.
7. Rushton EK, Jiang J, Leonard SS, Eberly S, Castranova V, Biswas P, et al. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A. 2010;73(5):445-61.
8. Cho WS, Duffin R, Thielbeer F, Bradley M, Megson IL, Macnee W, et al. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol Sci. 2012;126(2):469-77.
9. Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol. 2013;10:9.
10. Setyawati MI, Yuan X, Xie J, Leong DT. The influence of lysosomal stability of silver nanomaterials on their toxicity to human cells. Biomaterials. 2014;35(25):6707-15.
11. Ortega R, Bresson C, Darolles C, Gautier C, Roudeau S, Perrin L, et al. Low-solubility particles and a Trojan-horse type mechanism of toxicity: the case of cobalt oxide on human lung cells. Part Fibre Toxicol. 2014;11:14.
12. 4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis. Eur Respir J. 2012;39(3):546-57.
13. Silva RM, Xu J, Saiki C, Anderson DS, Franzi LM, Vulpe CD, et al. Short versus long silver nanowires: a comparison of in vivo pulmonary effects post instillation. Part Fibre Toxicol. 2014;11:52.
14. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8(7):543-57.
15. Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol. 2014;11:18.
16. Cho WS, Duffin R, Howie SE, Scotton CJ, Wallace WA, Macnee W, et al. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol. 2011;8(1):27.
17. Adamcakova-Dodd A, Stebounova LV, Kim JS, Vorrink SU, Ault AP, O'Shaughnessy PT, et al. Toxicity assessment of zinc oxide nanoparticles using sub-acute and sub-chronic murine inhalation models. Part Fibre Toxicol. 2014;11:15.
18. Kotchey GP, Hasan SA, Kapralov AA, Ha SH, Kim K, Shvedova AA, et al. A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials. Acc Chem Res. 2012;45(10):1770-81.
19. Stopford W, Turner J, Cappellini D, Brock T. Bioaccessibility testing of cobalt compounds. J Environ Monit. 2003;5(4):675-80.
20. Cho WS, Duffin R, Poland CA, Duschl A, Oostingh GJ, Macnee W, et al. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology. 2012;6:22-35.
21. 29 CFR1910.1000 Table Z-1, Occupational Safety and Health Regulations (OSHA Standards).
22. Cassee FR, Muijser H, Duistermaat E, Freijer JJ, Geerse KB, Marijnissen JC, et al. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol. 2002;76(5-6):277-86.
23. Castet D, Bouillard J. Acute pneumopathy caused by exposure to zinc oxide. Rev Mal Respir. 1992;9(6):632-3.
24. Cho WS, Duffin R, Poland CA, Howie SE, MacNee W, Bradley M, et al. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect. 2010;118(12):1699-706.
25. Proper SP, Saini Y, Greenwood KK, Bramble LA, Downing NJ, Harkema JR, et al. Loss of hypoxia-inducible factor 2 alpha in the lung alveolar epithelium of mice leads to enhanced eosinophilic inflammation in cobalt-induced lung injury. Toxicol Sci. 2014;137(2):447-57.
26. Szebeni J. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol. 2014;61(2):163-73.
27. Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, et al. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med. 2007;64(9):609-15.
28. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823-39.
29. Donaldson K, Tran CL. An introduction to the short-term toxicology of respirable industrial fibres. Mutat Res. 2004;553(1-2):5-9.
30. Schinwald A, Chernova T, Donaldson K. Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro. Part Fibre Toxicol. 2012;9:47.
31. Schinwald A, Murphy FA, Prina-Mello A, Poland CA, Byrne F, Movia D, et al. The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci. 2012;128(2):461-70.
32. Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, et al. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci. 2000;55(1):24-35.
33. Lison D, Laloy J, Corazzari I, Muller J, Rabolli V, Panin N, et al. Sintered indium-tin-oxide (ITO) particles: a new pneumotoxic entity. Toxicol Sci. 2009;108(2):472-81.